Buspirone Hydrochloride Tablet
Product Images NDC 24689-921

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 24689-921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apnar Pharma Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 01

Chemical structure diagram of buspirone hydrochloride, showing the molecular arrangement of its atoms including the cyclopropyl, piperazine, and pyrimidinyl groups. The diagram represents the active ingredient buspirone hydrochloride.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 02

Buspirone Hydrochloride 10 mg and 5 mg oral tablets. The first tablet is white, capsule-shaped, scored and printed with '1' on the left half and '00' on the right half. The second tablet is white, oblong, with three segments, imprinted with '555'. Both tablets are shown without packaging or labeling other than the imprints.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 03

Buspirone Hydrochloride 5 mg oral tablet with a scored line and the imprint '5 | 5'. The image shows one side of a white, round, scored tablet, indicating the dosage strength and facilitating dose splitting. Labeler: APNAR PHARMA LP.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 04

Close-up image of a Buspirone Hydrochloride 5 mg oral tablet showing an imprint with the number '5' on one side. The tablet has a scored line down the middle for splitting. The image is from a product labeled by APNAR PHARMA LP.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 05

A white, round-edged tablet imprinted with the number "5" on one side. This represents a 5 mg strength tablet of Buspirone Hydrochloride, an oral human prescription drug by APNAR PHARMA LP.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 06

An instructional line drawing showing four fingers, two from each hand, pressing on either side of a tablet to break it. This illustration likely demonstrates how to split a tablet for oral administration, associated with Buspirone Hydrochloride tablets.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 07

The image shows two white oral tablets of Buspirone Hydrochloride with scored lines. One tablet is split into two segments with the imprint '1' on one side and '01' on the other. The second tablet is divided into three segments and imprinted with '10 10 10' across them. No manufacturer or additional markings are visible on the tablets.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 08

Buspirone Hydrochloride 10 mg oral tablet imprinted with '10' on both sides of the scored line. The tablet is oval-shaped and white.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 09

Buspirone Hydrochloride 10 mg oral tablet imprinted with '10 | 1' design featuring a scored line separating the digits. The tablet is white and capsule-shaped with one rounded end.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 10

Image of a tablet imprinted with the number '10'. The round white tablet with the imprint is likely Buspirone Hydrochloride 10 mg oral tablet, labeled by APNAR PHARMA LP.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 11

An illustration depicting four hands holding a tablet and demonstrating how to split it along a scored line in the center. This instructional diagram relates to the Buspirone Hydrochloride oral tablet dosage form.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 12

Buspirone Hydrochloride Tablets, USP 5 mg tablet label from Apnar Pharma LP. The label includes the National Drug Code (NDC) number 24689-781-05 and indicates a package size of 500 tablets. Dosage instructions advise consulting the package insert. Storage guidelines specify 20° to 25°C (68° to 77°F) in a child-resistant container. Manufacturing is attributed to Inventia Healthcare Limited in India, with marketing by Apnar Pharma LP, Chino, California.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 13

The packaging label for Buspirone Hydrochloride Tablets, USP 7.5 mg, displays a count of 100 tablets. It includes storage instructions, dosage directions placeholder, and warnings to keep out of reach of children. The label shows the NDC 24689-785-01, manufacturer Inventia Healthcare Limited (India), and marketer Apnar Pharma LP (California). The label is predominantly white with blue and orange text highlights and includes barcodes on the right side.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 14

Packaging label for Buspirone Hydrochloride Tablets, USP, 10 mg oral tablets. The label indicates a count of 500 tablets with NDC 24689-907-05. It includes storage instructions, manufacturer details (Inventia Healthcare Limited, India), and marketer information (Apnar Pharma LP, Chino, CA). The label features dosage and safety warnings, a barcode, and the APNAR PHARMA logo.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 15

Buspirone Hydrochloride Tablets USP 15 mg oral tablets packaging label by APNAR PHARMA LP. The label shows a white and blue design with the NDC 24689-921-06 and a quantity of 60 tablets. It includes storage instructions (20° to 25°C), dispensing requirements, and manufacturer information: Inventia Healthcare Limited, India. The label states the product is prescription only and includes a barcode.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 16

Label for Buspirone Hydrochloride Tablets, USP 30 mg, oral tablets, by APNAR PHARMA LP. The label indicates 60 tablets per bottle with instructions for pharmacists to dispense with an information leaflet. It includes storage conditions, dosage directions referencing the package insert, manufacturer Inventia Healthcare Limited in India, and marketing by Apnar Pharma LP in California. The label features the NDC 24689-933-06 and various regulatory warnings.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 17

Buspirone Hydrochloride Tablets, USP 15 mg oral tablet label from Apnar Pharma LP. The label states the NDC 24689-921-05 and package contains 500 tablets. It includes storage instructions at 20° to 25°C and safety warnings. The label also has manufacturer Inventia Healthcare Limited, India, with marketer Apnar Pharma LP, Chino, CA.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 18

Label for Buspirone Hydrochloride Tablets, USP 5 mg by APNAR PHARMA LP. The label states 100 tablets, oral dosage form, prescription only. It includes storage instructions, dosing guidance to see package insert, manufacturer details (Inventia Healthcare Limited, India), and marketing information by Apnar Pharma LP, USA. Barcode and NDC 24689-781-01 are shown.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 19

Label for busPIRone Hydrochloride Tablets, USP 10 mg, oral tablets, 100 count. The label includes dosage information, storage instructions, and manufacturer details. Manufactured by Inventia Healthcare Limited in India and marketed by Apnar Pharma LP. Features barcode, NDC 24689-907-01, and child-resistant container information.*

FDA Label Image

B7db4c3d 72e4 420c 9b81 119646c13c85 20

Buspirone Hydrochloride Tablets, USP 15 mg oral tablet label from Apnar Pharma LP. The label specifies 100 tablets per bottle, with dosage information and storage instructions at 20° to 25°C. It includes manufacturer details for Inventia Healthcare Limited in India and marketing information for Apnar Pharma LP, Chino, CA. The label also displays barcodes and a green strength indicator.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.